Variable | After multiple imputation | ||
---|---|---|---|
Odds ratio | 95%CI | p-value | |
Age ≥ 90 | 92.63 | 16.66–514.98 | < 0.01 |
80–89 | 13.17 | 7.21–24.06 | < 0.01 |
70–79 | 6.92 | 4.23–11.31 | < 0.01 |
60–69 | 2.60 | 1.65–4.08 | < 0.01 |
59 ≤ (reference) | 1 | ||
Male | 1.04 | 0.74–1.46 | 0.82 |
Body mass index ≥ 30 kg/m2 | 1.37 | 0.91–2.07 | 0.14 |
Smoking history | 1.16 | 0.80–1.68 | 0.44 |
Comorbidity | 1.33 | 0.87–2.03 | 0.19 |
Immunosuppression | 2.17 | 1.14–4.12 | 0.02 |
Admission date | |||
3rd wave | 0.86 | 0.59–1.26 | 0.45 |
2nd wave | 0.62 | 0.41–0.95 | 0.03 |
1st wave (reference) | 1 | ||
Vital signs on admission | |||
Fever (≥ 38 °C) | 0.83 | 0.61–1.13 | 0.25 |
SpO2 < 90% | 1.00 | 0.68–1.46 | 0.99 |
Respiratory rate ≥ 30 | 1.02 | 0.70–1.50 | 0.90 |
Systolic blood pressure ≤ 80 mmHg | 0.25 | 0.07–0.96 | 0.04 |
ARDS | |||
Severe | 6.73 | 4.50–10.04 | < 0.01 |
Moderate | 0.63 | 0.39–1.02 | 0.06 |
Mild | 0.54 | 0.23–1.28 | 0.16 |
None (reference) | 1 | ||
Drug administration for COVID-19 | 0.97 | 0.56–1.67 | 0.90 |
Steroid use | 1.26 | 0.84–1.88 | 0.26 |
Drug administration for coagulopathy | 0.96 | 0.68–1.35 | 0.82 |
Days from symptom onset to IMV | 1.00 | 1.00–1.01 | 0.47 |